Cargando…

FKBP4 is a malignant indicator in luminal A subtype of breast cancer

Purpose: FKBP4 is a member of the immunophilin protein family, which plays a role in immunoregulation and basic cellular processes involving protein folding and trafficking associated with HSP90. However, the relationship between abnormal expression of FKBP4 and clinical outcome in luminal A subtype...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiong, Hanchu, Chen, Zihan, Zheng, Wenwen, Sun, Jing, Fu, Qingshuang, Teng, Rongyue, Chen, Jida, Xie, Shuduo, Wang, Linbo, Yu, Xiao-Fang, Zhou, Jichun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052866/ https://www.ncbi.nlm.nih.gov/pubmed/32194784 http://dx.doi.org/10.7150/jca.40982

Ejemplares similares

Contrast of Mastoscopic and Conventional Axillary Lymph Node Dissection of Patients With Breast Cancer: Meta-Analysis
por: Xiong, Hanchu, et al.
Publicado: (2020)

FKBP5 associated CD8 T cell infiltration is a novel prognostic biomarker in luminal B breast cancer
por: Tong, Fei, et al.
Publicado: (2023)

Naringenin Regulates FKBP4/NR3C1/NRF2 Axis in Autophagy and Proliferation of Breast Cancer and Differentiation and Maturation of Dendritic Cell
por: Xiong, Hanchu, et al.
Publicado: (2022)

Endocrine resistance in breast cancer: Current status and a perspective on the roles of miRNAs (Review)
por: ZHOU, JICHUN, et al.
Publicado: (2013)

The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy
por: Wang, Ji, et al.
Publicado: (2019)

Integrated analysis of FKBP1A/SLC3A2 axis in everolimus inducing ferroptosis of breast cancer and anti-proliferation of T lymphocyte
por: Chen, Zihan, et al.
Publicado: (2023)

Overexpression of Lin28 Decreases the Chemosensitivity of Gastric Cancer Cells to Oxaliplatin, Paclitaxel, Doxorubicin, and Fluorouracil in Part via microRNA-107
por: Teng, Rongyue, et al.
Publicado: (2015)

Glucose transporter GLUT1 expression and clinical outcome in solid tumors: a systematic review and meta-analysis
por: Wang, Ji, et al.
Publicado: (2017)

Tumor and serum gamma-glutamyl transpeptidase, new prognostic and molecular interpretation of an old biomarker in gastric cancer
por: Wang, Qinchuan, et al.
Publicado: (2017)

Comprehensive analysis of FKBP4/NR3C1/TMEM173 signaling pathway in triple-negative breast cancer cell and dendritic cell among tumor microenvironment
por: Xiong, Hanchu, et al.
Publicado: (2022)

A predictive signature for oxaliplatin and 5-fluorouracil based chemotherapy in locally advanced gastric cancer
por: Wang, Qinchuan, et al.
Publicado: (2020)

Retraction Notice to: Comprehensive analysis of FKBP4/NR3C1/TMEM173 signaling pathway in triple-negative breast cancer cell and dendritic cell among tumor microenvironment
por: Xiong, Hanchu, et al.
Publicado: (2022)

Dysregulation of long non-coding RNA in breast cancer: an overview of mechanism and clinical implication
por: Wang, Ji, et al.
Publicado: (2016)

Regulation of tamoxifen sensitivity by the PLAC8/MAPK pathway axis is antagonized by curcumin-induced protein stability change
por: Mao, Misha, et al.
Publicado: (2021)

Approaches and genetic determinants in predicting response to neoadjuvant chemotherapy in locally advanced gastric cancer
por: Zhou, Jichun, et al.
Publicado: (2016)

Matrix metalloproteinase-1 expression in breast carcinoma: a marker for unfavorable prognosis
por: Wang, Ji, et al.
Publicado: (2017)

Pegylated Liposomal Doxorubicin Versus Epirubicin as Adjuvant Therapy for Stage I–III Breast Cancer
por: Hu, Wenxian, et al.
Publicado: (2021)

A retrospective comparative study on the diagnostic efficacy and the complications: between CassiII rotational core biopsy and core needle biopsy
por: Xie, Shuduo, et al.
Publicado: (2023)

Oncogenic mechanisms of Lin28 in breast cancer: new functions and therapeutic opportunities
por: Xiong, Hanchu, et al.
Publicado: (2017)

Subcellular Expression Patterns of FKBP Prolyl Isomerase 10 (FKBP10) in Colorectal Cancer and Its Clinical Significance
por: Fu, Yating, et al.
Publicado: (2023)

The role of lncRNA H19 in tumorigenesis and drug resistance of human Cancers
por: Zhang, Xun, et al.
Publicado: (2022)

Prognostic parameters of luminal A and luminal B intrinsic breast cancer subtypes of Pakistani patients
por: Hashmi, Atif Ali, et al.
Publicado: (2018)

Elevated FKBP52 expression indicates a poor outcome in patients with breast cancer
por: Hong, Chaoqun, et al.
Publicado: (2017)

FKBP51 and FKBP12.6—Novel and tight interactors of Glomulin
por: Hähle, Andreas, et al.
Publicado: (2019)

Exosome: emerging biomarker in breast cancer
por: Jia, Yunlu, et al.
Publicado: (2017)

FKBP14 overexpression contributes to osteosarcoma carcinogenesis and indicates poor survival outcome
por: Huang, Zhongming, et al.
Publicado: (2016)

Biological Actions of the Hsp90-binding Immunophilins FKBP51 and FKBP52
por: Zgajnar, Nadia R., et al.
Publicado: (2019)

Modulating FKBP5/FKBP51 and autophagy lowers HTT (huntingtin) levels
por: Bailus, Barbara J., et al.
Publicado: (2021)

DNA Methylation of FKBP5 as Predictor of Overall Survival in Malignant Pleural Mesothelioma
por: Cugliari, Giovanni, et al.
Publicado: (2020)

Ki-67 (30-9) scoring and differentiation of Luminal A- and Luminal B-like breast cancer subtypes
por: Viale, Giuseppe, et al.
Publicado: (2019)

CXCL12 and CXCR4 as Potential Early Biomarkers for Luminal A and Luminal B Subtypes of Breast Cancer
por: Motyka, Joanna, et al.
Publicado: (2023)

Application of DCE-MRI radiomics signature analysis in differentiating molecular subtypes of luminal and non-luminal breast cancer
por: Huang, Ting, et al.
Publicado: (2023)

Identification of a Novel Luminal Molecular Subtype of Breast Cancer
por: Dvorkin-Gheva, Anna, et al.
Publicado: (2014)

A New Anti-Depressive Strategy for the Elderly: Ablation of FKBP5/FKBP51
por: O'Leary, John C., et al.
Publicado: (2011)

FKBP52 and FKBP51 differentially regulate the stability of estrogen receptor in breast cancer
por: Habara, Makoto, et al.
Publicado: (2022)

FKBP11 improves the malignant property of osteosarcoma cells and acts as a prognostic factor of osteosarcoma
por: Zeng, Duo, et al.
Publicado: (2023)

MRI texture analysis in differentiating luminal A and luminal B breast cancer molecular subtypes - a feasibility study
por: Holli-Helenius, Kirsi, et al.
Publicado: (2017)

The role of estrogen receptor alpha in mediating chemoresistance in breast cancer cells
por: Jiang, Zhinong, et al.
Publicado: (2012)

The Many Faces of FKBP51
por: Hähle, Andreas, et al.
Publicado: (2019)

Metformin induces Ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer
por: Yang, Jingjing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_iuqbqe7u4vsb98ff77t5ilpupq